North Carolina 2025 Session Status: Enacted Bipartisan · 24 R · 2 D cosponsors

SB 479 — SCRIPT Act.

Last action — Signed by Gov. 7/9/2025

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced March 25, 2025. Enacted.

Signed by Governor Josh Stein (Democratic) on July 09, 2025.

Prognosis

Likely to advance 98% · high confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 26 sponsors

    2 primary, 24 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (24 R · 2 D) — cross-party backing.

  • Cleared a recorded vote

    Passed 2 recorded votes so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

What changed in the latest version

628 added · 664 removed

Plain-language change summary

In the latest version of Bill SB 479, the definition of a "pharmacy desert" has changed, increasing the distance from 10 miles to 15 miles for rural communities without a pharmacy, and the population threshold for these areas has been raised from 5,000 to 20,000 residents. Additionally, the proximity qualification for communities has also increased from a 1-mile radius to a 2-mile radius. These changes aim to adjust support mechanisms for pharmacies in under-served areas, potentially making it easier for them to access necessary resources and assistance.

→
Previous
Latest
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2025 S 2 SENATE BILL 479 Health Care Committee Substitute Adopted 4/10/25 Short Title:
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2025 S 1 SENATE BILL 479 Short Title:
Senators Sawrey, Britt, and Galey (Primary Sponsors).
March 26, 2025 A BILL TO BE ENTITLED AN ACT SUPPORTING COMMUNITY RETAIL PHARMACIES AND IMPROVING TRANSPARENCY.
Rules and Operations of the Senate March 26, 2025 A BILL TO BE ENTITLED AN ACT SUPPORTING COMMUNITY RETAIL PHARMACIES AND IMPROVING TRANSPARENCY.
*S479-v-2* General Assembly Of North Carolina Session 2025 (4) "Health Health benefit plan" is as that term is plan.
*S479-v-1* General Assembly Of North Carolina Session 2025 (4) "Health Health benefit plan" is as that term is plan.
An urban community or neighborhood without a pharmacy within a 2-mile radius of any point in the community or neighborhood.
An urban community or neighborhood without a pharmacy within a 1-mile radius of any point in the community or neighborhood.
A rural community without a pharmacy within a 15-mile radius of any point in the community.
A rural community without a pharmacy within a 10-mile radius of any point in the community.
(3) Impose upon a beneficiary of pharmacy services under a health benefit plan an insured any copayment, fee, or condition that is not equally imposed upon all beneficiaries insureds in the same benefit category, class, or copayment Page 2 Senate Bill 479-Second Edition General Assembly Of North Carolina Session 2025 level under the health benefit plan when receiving services from a contract provider;provider.
(3) Impose upon a beneficiary of pharmacy services under a health benefit plan an insured any copayment, fee, or condition that is not equally imposed upon all beneficiaries insureds in the same benefit category, class, or copayment Page 2 Senate Bill 479-First Edition General Assembly Of North Carolina Session 2025 level under the health benefit plan when receiving services from a contract provider;provider.
Prohibitions on the imposition of a monetary advantage shall not apply to monetary advantages imposed upon a pharmacy located in a pharmacy desert or a county with a population of fewer than 20,000 residents.
Prohibitions on the imposition of a monetary advantage shall not apply monetary advantages imposed upon a pharmacy located in a pharmacy desert or a county with a population of fewer than 5,000 residents.
Nothing in this section shall prevent a pharmaceutical Senate Bill 479-Second Edition Page 3 General Assembly Of North Carolina Session 2025 manufacturer or wholesale distributor of pharmaceutical products from providing special prices, marketing incentives, rebates, or discounts to different purchasers not prohibited by federal and State antitrust laws.
Nothing in this section shall prevent a pharmaceutical Senate Bill 479-First Edition Page 3 General Assembly Of North Carolina Session 2025 manufacturer or wholesale distributor of pharmaceutical products from providing special prices, marketing incentives, rebates, or discounts to different purchasers not prohibited by federal and State antitrust laws.
Page 4 Senate Bill 479-Second Edition General Assembly Of North Carolina Session 2025 e.
Page 4 Senate Bill 479-First Edition General Assembly Of North Carolina Session 2025 e.
Senate Bill 479-Second Edition Page 5 General Assembly Of North Carolina Session 2025 (b) To Independent Pharmacies, PBMs, and Third-Party Payers.
Senate Bill 479-First Edition Page 5 General Assembly Of North Carolina Session 2025 (b) To Independent Pharmacies, PBMs, and Third-Party Payers.
"§ 58-56B-25.
Reporting patient cost-sharing assistance.
A PSAO that provides, accepts, or possesses a discount, concession, or product voucher in order to reduce, directly or indirectly, a beneficiary's or insured's out-of-pocket expense for the order, dispensing, substitution, sale, or purchase of a prescription drug shall provide to the Department an annual report that includes all of the following information:
(1) The aggregated total of all transactions for which the PSAO provided, accepted, or possessed a discount, concession, or product voucher described in this section by an independent pharmacy.
Page 6 Senate Bill 479-First Edition General Assembly Of North Carolina Session 2025 (2) The aggregated total of any payments received by the PSAO itself providing, accepting, or possessing a discount, concession, or product voucher described in this section on behalf of an independent pharmacy.
– A PSAO that owns or is owned by, in whole or in part, any entity that manufactures, sells, or distributes prescription drugs, biological products, or medical devices shall disclose to the Department any agreement with an independent pharmacy Page 6 Senate Bill 479-Second Edition General Assembly Of North Carolina Session 2025 to purchase prescription drugs, biological products, or medical devices by an independent pharmacy from the PSAO or an entity with which the PSAO has an ownership interest or that has an ownership in the PSAO.
– A PSAO that owns or is owned by, in whole or in part, any entity that manufactures, sells, or distributes prescription drugs, biological products, or medical devices shall disclose to the Department any agreement with an independent pharmacy to purchase prescription drugs, biological products, or medical devices by an independent pharmacy from the PSAO or an entity with which the PSAO has an ownership interest or that has an ownership in the PSAO.
Fiduciary duty.
A PSAO must act as a fiduciary and perform its duties to a pharmacy exercising good faith and fair dealing.
A PSAO has a duty to avoid self-dealing and conflicts of interest." SECTION 2.1A.(a) Article 56B of Chapter 58 of the General Statutes, as amended by Section 2.1 of this act, is amended by adding a new section to read:
"§ 58-56B-50.
The Commissioner of Insurance is authorized to adopt rules, temporary or otherwise, regarding the administration of this Article." SECTION 2.1A.(b) No later than October 1, 2026, the Commissioner of Insurance shall adopt rules necessary to implement Part II of this act.
The Commissioner of Insurance is authorized to adopt rules, temporary or otherwise, regarding the administration of this Article." Senate Bill 479-First Edition Page 7 General Assembly Of North Carolina Session 2025 SECTION 2.2.
SECTION 2.1A.(c) This section is effective when it becomes law.
This Part is effective October 1, 2026, and applies to contracts entered into, renewed, or amended on or after that date.
SECTION 2.2.
4 PART III.
Except as otherwise provided, this Part is effective October 1, 2026, and applies to contracts entered into, renewed, or amended on or after that date.
PHARMACY BENEFITS MANAGER TRANSPARENCY, FAIR REIMBURSEMENT, AND FIDUCIARY DUTIES SECTION 3.1.(a) Article 56A of Chapter 58 of the General Statutes is amended by adding a new section to read:
PART III.
PHARMACY BENEFITS MANAGER TRANSPARENCY, FAIR REIMBURSEMENT, AND FIDUCIARY DUTIES Senate Bill 479-Second Edition Page 7 General Assembly Of North Carolina Session 2025 SECTION 3.1.(a) Article 56A of Chapter 58 of the General Statutes is amended by adding a new section to read:
– No later than May 1 of every year, all pharmacy benefits managers shall report to the Commissioner all of the following information regarding prescription drug benefits specific to insurers within the State with which a pharmacy benefits manager has a contract:
– No later than March 1 of every year, all pharmacy benefits managers shall report to the Commissioner all of the following information regarding prescription drug benefits specific to insurers within the State with which a pharmacy benefits manager has a contract:
(2) The aggregated amount of difference between the amount paid by the health benefit plan for prescription drugs and the aggregated amount paid to pharmacies for claims paid under the health benefit plan, including point-of-sale and retroactive charges.
(2) Details on any fees, other than rebates, that the pharmacy benefits manager received from a drug manufacturer or wholesale distributor.
(3) The spread between aggregate amount paid to pharmacies for prescription drugs and the aggregated amount charged to insurers for prescription drugs.
(3) The average amount paid to pharmacies for each type of prescription drug or device, net of the aggregate average amount of fees or other assessments that are imposed upon the pharmacies, including point-of-sale and retroactive charges.
(4) A list of all pharmacies that are under common control or ownership of the pharmacy benefits manager.
(4) Any spread between the average net amount paid to pharmacies under subdivision (3) of this subsection and average the amount charged to the insurers.
(5) A pharmacy benefits manager that is affiliated with a retail pharmacy shall provide the aggregated amount of anydifferences between what the pharmacy benefits manager reimburses or charges affiliated retail pharmacies and what it reimburses or charges non-affiliated retail pharmacies.
(5) A list of all pharmacies that are under common control or ownership of the pharmacy benefits manager.
(6) The aggregate amount of all fees or other assessments, including point-of-sale and retroactive charges, that are imposed on, or collected from, contracted, preferred,orin-networkpharmacies.Retroactivechargesshallnotincludeany funds recouped from an audit conducted under Part 8 of Article 50 of Chapter 58 of the General Statutes.
(6) The aggregate amount of anydifferences between what the pharmacybenefits manager reimburses or charges, either of the following:
(7) The aggregate amount of rebates and fees that were passed on to either the insurer with which the pharmacy benefits manager is contracted or an insured at the point-of-sale of a prescription drug.
a.
(8) The highest, lowest, and mean aggregate percentages for retained rebates by the pharmacy benefits manager.
Pharmacies owned or controlled by, or otherwise affiliated with, the pharmacy benefits manager.
b.
Pharmacies not owned or controlled by, or otherwise affiliated with, the pharmacy benefits manager on behalf of a health benefit plan offered by the insurer.
(7) The aggregate amount of all fees or other assessments, including point-of-sale and retroactive charges, that are imposed on, or collected from, contracted, preferred, or in-network pharmacies.
(8) The aggregate amount of rebates and fees that were passed on to either the insurer with which the pharmacy benefits manager is contracted or an insured at the point-of-sale of a prescription drug.
(9) The highest, lowest, and mean aggregate percentages for retained rebates by the pharmacy benefits manager.
Show all 121 changed rows (81 more)
Previous
Latest
Information contained in this report is not considered a public record under Chapter 132 of the General Statutes or under G.S.
Information Page 8 Senate Bill 479-First Edition General Assembly Of North Carolina Session 2025 contained in this report is not considered a public record under Chapter 132 of the General Statutes or under G.S.
"(g) No pharmacy benefits manager contract may require, either directly or indirectly or through a pharmacy services administration organization, an independent pharmacy to accept reimbursement for providing a covered prescription drug, device, or service at a rate less than the acquisition cost for the covered drug, device, or service.
"(g) No pharmacy benefits manager contract may require, either directly or indirectly or through a pharmacy services administration organization, a pharmacy or pharmacist to accept reimbursement for providing a covered prescription drug, device, or service at a rate that is less than the acquisition cost for the covered drug, device, or service.
75-1.1 and is subject to all of the enforcement and penalty provisions of an unfair trade practice under this Chapter and under Article 1 of Chapter 75 of the General Statutes." Page 8 Senate Bill 479-Second Edition General Assembly Of North Carolina Session 2025 SECTION 3.2.(b) G.S.
75-1.1 and is subject to all of the enforcement and penalty provisions of an unfair trade practice under this Chapter and under Article 1 of Chapter 75 of the General Statutes." SECTION 3.2.(b) G.S.
58-56A-4(g), any independent pharmacy or pharmacist who has a contract, either directly or through a pharmacy services administration organization, with a pharmacy benefits manager administering any type of drug or pharmacy benefit plan to provide covered drugs, devices, or services at a contractual reimbursement rate may decline to provide a covered drug, device, or service if the pharmacy or pharmacist will be or is paid less than the acquisition cost forthe covered drug,device, or service.
58-56A-4(g), any pharmacy or pharmacist who has a contract, either directly or through a pharmacy services administration organization, with a pharmacy benefits manager administering any type of drug or pharmacy benefit plan to provide covered drugs, devices, or services at a contractual reimbursement rate may decline to provide a covered drug, device, or service if the pharmacy or pharmacist will be or is paid less than the acquisition cost forthe covered drug,device, or service.
The pharmacy benefits manager shall also provide the cost that it paid for the specified outpatient prescription drug, including the ingredient cost and the dispensing fee." SECTION 3.5.
The pharmacy benefits manager shall also provide the cost that it paid for the specified outpatient prescription drug, including the ingredient cost and the dispensing fee." Senate Bill 479-First Edition Page 9 General Assembly Of North Carolina Session 2025 SECTION 3.5.
PART IV.
4 PART IV.
Senate Bill 479-Second Edition Page 9 General Assembly Of North Carolina Session 2025 (a) A pharmacy benefits manager shall not deny the right to any properly licensed pharmacist or pharmacy to participate in a retail pharmacy network on the same terms and conditions of other similarly situated participants in the network.
(a) A pharmacy benefits manager shall not deny the right to any properly licensed pharmacist or pharmacy to participate in a retail pharmacy network on the same terms and conditions of other similarly situated participants in the network.
This Part is effective October 1, 2025, and applies to contracts entered into, renewed, or amended on or after that date.
This section is effective October 1, 2025, and applies to contracts entered into, renewed, or amended on or after that date.
The independent pharmacy may refer the prescription to a pharmacy that only provides centralized pharmacy services in this State through the mail or remote medication order processing services subject to the Board's rules if the independent pharmacy makes a determination the provision of pharmaceutical services through the mail does not harm the patient." SECTION5.2.
The independent pharmacy may refer the prescription to a pharmacy that only provides centralized pharmacy services in this State through the mail or remote medication Page 10 Senate Bill 479-First Edition General Assembly Of North Carolina Session 2025 order processing services subject to the Board's rules if the independent pharmacy makes a determination the provision of pharmaceutical services through the mail does not harm the patient." SECTION 5.2.
NolaterthanOctober1,2025,theNorthCarolinaBoardofPharmacy shall adopt rules to implement this Part.
The North Carolina Board of Pharmacy shall adopt rules to implement this act.
Section 5.1 of this Part becomes effective October 1, 2025.
This Part becomes effective October 1, 2025.
The remainder of this Part is effective when it becomes law.
8 PART VI.
PART VI.
STRENGTHEN PHARMACY AUDIT PROTECTIONS SECTION 6.1.(a) Article 4C of Chapter 90 of the General Statutes is recodified as Part 8 of Article 50 of Chapter 58 of the General Statutes, as follows:
STRENGTHEN PHARMACY AUDIT PROTECTIONS Page 10 Senate Bill 479-Second Edition General Assembly Of North Carolina Session 2025 SECTION 6.1.(a) Article 4C of Chapter 90 of the General Statutes is recodified as Part 8 of Article 50 of Chapter 58 of the General Statutes, as follows:
(1) Auditing entity.
Senate Bill 479-First Edition Page 11 General Assembly Of North Carolina Session 2025 (1) Auditing entity.
(2) Claim.
(2) Reserved for future codification purposes.
– A request for reimbursement submitted by a pharmacyor pharmacist to a pharmacy benefits manager for a single fill or refill of any drug, product, ormedicationforwhichaprescriptioniswrittenbyalicensedprescriberunder applicable State or federal law, or pharmacist-provided service, that has been adjudicated and processed by the pharmacy benefits manager.
Each fill or Senate Bill 479-Second Edition Page 11 General Assembly Of North Carolina Session 2025 refill shall constitute a separate and distinct claim, regardless of the number of days' supply or quantity dispensed.
(8) If an audit reveals the necessity for a review of additional claims, to have the audit conducted on site.
(8) If an audit reveals the necessity for a review of additional claims, to have the the audit conducted on site.
(9) Except for audits initiated for the reason described in subdivision (6) of this subsection, to be subject to no No more than one audit in one calendar year, Page 12 Senate Bill 479-Second Edition General Assembly Of North Carolina Session 2025 unless fraud or misrepresentation is reasonably suspected.suspected or unless an audit is conducted for an identifiable problem.
Page 12 Senate Bill 479-First Edition General Assembly Of North Carolina Session 2025 (9) Except for audits initiated for the reason described in subdivision (6) of this subsection, to be subject to no No more than one audit in one calendar year, unless fraud or misrepresentation is reasonably suspected.suspected or unless an audit is conducted for an identifiable problem.
(16) To have an An audit based onlyon information obtained bythe auditing entity conducting the audit and not based on any audit report or other information gained from an audit conductedbyadifferent auditingentity.
(16) To have an An audit based onlyon information obtained bythe auditing entity conducting the audit and not based on any audit report or other information gained from an audit conductedbyadifferent auditingentity.This subdivision does not prohibit an auditing entity from using an earlier audit report prepared by that auditing entity for the same pharmacy.
This subdivision does not prohibit an auditing entity from using an earlier audit report prepared by that auditing entity for the same pharmacy.
(1) The responsible party and the entity conducting the audit have entered into a contract that explicitly states the percentage charge or assessment to the responsible party.
Senate Bill 479-First Edition Page 13 General Assembly Of North Carolina Session 2025 (1) The responsible party and the entity conducting the audit have entered into a contract that explicitly states the percentage charge or assessment to the responsible party.
Senate Bill 479-Second Edition Page 13 General Assembly Of North Carolina Session 2025 (2) A commission or other payment to an agent or employee of the entity conducting the audit is not based, directly or indirectly, on amounts recouped.
(2) A commission or other payment to an agent or employee of the entity conducting the audit is not based, directly or indirectly, on amounts recouped.
Fraud There is fraud or other intentional and willful misrepresentation evidenced bya reviewof theclaims data, statements, physical review, orother investigative methods.
Fraud There is fraud or other intentional and willful misrepresentation evidenced bya reviewof theclaims data, statements, physical review,orother investigative methods.
f.(6) There was insufficient documentation, including electronically stored information, as described in this subsection.that did not meet the standards set by the North Carolina Board of Pharmacy.
Page 14 Senate Bill 479-First Edition General Assembly Of North Carolina Session 2025 f.(6) There was insufficient documentation, including electronically stored information, as described in this subsection.that did not meet the standards set by the North Carolina Board of Pharmacy.
Page 14 Senate Bill 479-Second Edition General Assembly Of North Carolina Session 2025 g.(7) Fraud There is evidence of fraud or other intentional and willful misrepresentation by the pharmacy.
g.(7) Fraud There is evidence of fraud or other intentional and willful misrepresentation by the pharmacy.
"(7) If an audit is conducted for a reason other than an identified problem, limitation oftheaudit to 100selectedprescriptions.onepercent (1%)of claims or 100 claims, whichever is less." SECTION 6.2.(b) G.S.
"(7) If an audit is conducted for a reason other than an identified problem, limitation of the audit to 100 selected prescriptions.25 total prescriptions, including prescription refills." SECTION 6.2.(b) G.S.
"(8) If an audit reveals the necessity for a review of additional claims, to have the audit conducted on site.site upon request by the pharmacy.
"(8) If an audit reveals the necessity for a review of additional claims, the audit conducted on site.site upon request bythe pharmacy.
Except in the case of an identified problem, the pharmacy shall also be entitled to written notice provided at least 14 days prior to any audit of additional claims that details the basis for the review of additional claims, including a specific description of any suspected fraud or abuse." SECTION 6.2.(c) G.S.
The pharmacyshall also be entitled to written notice provided at least 14 days prior to any audit of additional claims that details the basis for the review of additional claims, including a specific description of any suspected fraud or abuse." SECTION 6.2.(c) G.S.
58-50-410, as created by Section 6.1(a) of this Part and as amended by Section 6.1(b) of this Part, is further amended by adding a new subsection to read:
58-50-410(j), as created by Section 6.1(a) of this Part and as amended by Section 6.1(b) of this Part, is further amended by adding a new subsection to read:
"(j) Prior to any recoupment, the auditing entity shall provide the pharmacy with a summary describing the total recoupment amount and the approximate date on which the recoupment will occur.
"(j) Prior to any recoupment, the auditing entity shall provide the pharmacy with a summary describing the total recoupment amount and the date on which the recoupment will occur.
This summaryshall be accompanied bypayment summaries or electronic remittance advices documenting any disputed funds, charges, or other penalties." SECTION 6.2.(d) Part 8 of Article 50 of Chapter 58 of the General Statutes, as created by Section 6.1(a) of this Part, is amended by adding a new section to read:
This summary shall be accompanied by payment summaries or electronic remittance advices documenting any disputed funds, charges, or other penalties." SECTION 6.2.(d) Part 8 of Article 50 of Chapter 58 of the General Statutes, as created by Section 6.1(a) of this Part, is amended by adding a new section to read:
"§ 58-50-429.
Senate Bill 479-First Edition Page 15 General Assembly Of North Carolina Session 2025 "§ 58-50-429.
Senate Bill 479-Second Edition Page 15 General Assembly Of North Carolina Session 2025 (b) A violation of this Part is an unfair trade under G.S.
(b) A violation of this Part is an unfair trade under G.S.
8 PART VII.
PART VII.
(b) A pharmacy benefits manager shall not reimburse a pharmacy or pharmacist in this State an amount less than the amount that the pharmacybenefits manager reimburses a pharmacy benefits manager affiliate for providing the same pharmacist services or same prescription drug.
(b) A pharmacy benefits manager shall not reimburse a pharmacy or pharmacist an amount less than the amount that the pharmacybenefits manager reimburses a pharmacybenefits manager affiliate for providing the same pharmacist services or same prescription drug.
In determiningthe amount ofthe reimbursement forthepurposes of this section, theamount shall becalculated on aper-unit basis usingthesamegenericproduct identifierorgenericcodenumber and shall reflect all drug manufacturer's rebates, all direct and indirect administrative fees, and any other cost-savings or discounts that may be given related to the drug or services.
In determining the amount of the reimbursement for the purposes of this section, the amount shall becalculated on aper-unit basis usingthesamegenericproduct identifierorgenericcodenumber and shall reflect all drug manufacturer's rebates, all direct and indirect administrative fees, and any other cost-savings or discounts that may be given related to the drug or services.
(4) Rebate.
(4) Pharmacyrebate.
– A formulary discount or price concession attributable to the utilization of prescription drugs in the State and that is paid by a manufacturer to a pharmacy benefits manager.
– Revenue from a pharmacygroup purchasingorganization, a pharmacy or rebate aggregator, including pharmacy benefits managers, a third party, or a manufacturer that is in any way related to the insurer's provision of pharmacy benefits for coverage of a drug related to a distinct claim.
(b) When calculating an insured's defined cost-sharing for a covered prescription drug at the point of sale, an insurer offering a health benefit plan shall base the calculation on the price of the prescription drug after taking into account all rebates associated with that prescription drug.
(b) When calculating an insured's defined cost-sharing for a covered prescription drug at the point of sale, an insurer offering a health benefit plan shall base the calculation on the price of the prescription drug after taking into account all pharmacy rebates associated with that prescription drug.
The price of the prescription drug and any defined cost-sharing shall be reduced by an amount equal to ninety percent (90%) of all rebates received, or to be received, in conjunction with the dispensing or administration of the prescription drug.
The price of the prescription drug and any defined cost-sharing shall be reduced by an amount equal to ninety percent (90%) of all pharmacy rebates received, or to be received, in conjunction with the dispensing or administration of the prescription drug.
(c) Nothing in this section shall preclude an insurer from decreasing an insured's defined cost-sharing by an amount greater than that required under this section.
Page 16 Senate Bill 479-First Edition General Assembly Of North Carolina Session 2025 (c) Nothing in this section shall preclude an insurer from decreasing an insured's defined cost-sharing by an amount greater than that required under this section.
(d) By January 1 of each year, each insurer offering a health benefit plan shall submit to the Commissioner a certification attesting that, for all health benefit plans offered in this State by Page 16 Senate Bill 479-Second Edition General Assembly Of North Carolina Session 2025 the insurer, the insurer has complied with the requirements of this section.
(d) By January 1 of each year, each insurer offering a health benefit plan shall submit to the Commissioner a certification attesting that, for all health benefit plans offered in this State by the insurer, the insurer has complied with the requirements of this section.
(6) Price.
(6) Secretary.
– The wholesale acquisition cost as defined in 42 U.S.C.
§ 1395w-3a(c)(6)(B).
(7) Secretary.
– By January 31 of each year, a manufacturer shall notify all interested parties of each increase in price of fifteen percent (15%) or greater that occurred in the prior calendar year for a prescription drug with a price of one hundred dollars ($100.00) or more for a 30-day supply.
– In each calendar year, a manufacturer shall notify all interested parties of the 20 highest drug price increases imposed by the manufacturer during that year as set forth in this subsection.
The manufacturer shall disclose all of the following to interested parties for each drug price increase noticed for the prior calendar year under this subsection:
No later than January 31, the manufacturer shall disclose all of the following for the prior calendar year to interested parties for each drug price increase noticed under this subsection:
(2) A schedule of price increases for the drug for the five years prior to the calendar year for which the drug price increase was required to be noticed under this subsection.
Senate Bill 479-First Edition Page 17 General Assembly Of North Carolina Session 2025 (2) A schedule of price increases for the drug for the five years prior to the calendar year for which the drug price increase was required to be noticed under this subsection.
Senate Bill 479-Second Edition Page 17 General Assembly Of North Carolina Session 2025 (b) New Products.
(b) New Products.
– A manufacturer shall notify all interested parties of the price of any new prescription drug within three days after it is made available for purchase in this State.
– A manufacturer shall notify all interested parties of the price of any new prescription drug within three days after the manufacturer receives approval by the United States Food and Drug Administration.
(c) Satisfaction of Obligations.
– A manufacturer's obligations under this section shall be fully satisfied by the submission of information and data that a manufacturer includes in its annual consolidated report on Securities and Exchange Commission Form 10-K or any other public disclosure.
(d) Information is Not Public Record.
– Information provided to the Secretary or an interested party pursuant to this section shall, except to the extent it is already in the public domain, be considered trade secret under Article 24 of Chapter 66 of the General Statutes, confidential, exempt from public inspection and copying under Chapter 132 of the General Statutes, and shall not be disclosed directly or indirectly.
The Secretary, interested parties, and their agents shall not publish or otherwise disclose any information that would allow for the identification ofan individual drug,therapeuticclass ofdrugs, ormanufacturer,that would reveal the prices of any drug or therapeutic class of drugs, or that has the potential to compromise the financial, competitive, or proprietary nature of any information submitted by the manufacturer pursuant to this section.
The Secretary and interested parties shall impose the confidentiality protections of this section on any downstream third party that may receive or otherwise have access to this information.
– The Secretary shall develop a plan to collect data from manufacturers pursuant to G.S.
– The Secretary shall develop a plan to collect data from manufacturers related to the cost and pricing of prescription drugs to provide transparency and accountability for prescription drug pricing.
90-85.56 to provide transparency and accountability for prescription drug pricing.
The Secretary shall consult with other state and national agencies and nonprofit organizations to determine how to implement this data collection directive.
The Secretary shall consult with other state and national agencies and nonprofit organizations to determine how to implement this data collection directive but shall not disclose any confidential, proprietary, or trade secret information.
As partofthe first annual report required bysubsection (c)of this section,theSecretary shall submit a plan for the implementation of the data collection directive required by this subsection.
PHARMACY REPORTING REQUIREMENTS SECTION 10.
EFFECTIVE DATE SECTION 10.1.
Article 4A of Chapter 90 of the General Statutes is amended by adding a new section to read:
Page 18 Senate Bill 479-Second Edition General Assembly Of North Carolina Session 2025 "§ 90-85.42.
Board of Pharmacy reporting.
(a) Definitions.
– The following definitions apply in this section:
(1) Chain pharmacy.
– Four or more pharmacies under a common ownership.
(2) Independent pharmacy.
– Three or fewer pharmacies under a common ownership.
(b) Reporting Requirements.
– No later than October 1 of each year, the Board shall report the following information to the Department of Insurance and the Joint Legislative Oversight Committee on Health and Human Services:
(1) The current number of licensed pharmacies in the State.
(2) Thenumber of independent pharmacies thathave opened in theprecedingfive years.
(3) The number of chain pharmacies that have opened in the preceding five years.
(4) The number of independent pharmacies that have closed in the preceding five years.
(5) The number of chain pharmacies that have closed in the precedingfive years." PART XI.
EFFECTIVE DATE SECTION 11.1.
Senate Bill 479-Second Edition Page 19
Page 18 Senate Bill 479-First Edition
View plain text versions (9)

Amendments

1 amendment

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. Signed by Gov. 7/9/2025

  2. Ch. SL 2025-69

  3. Ratified

  4. Pres. To Gov. 6/30/2025

  5. Conf Com Reported

  6. Placed on Today's Calendar

  7. Conf Report Adopted

  8. Conf Com Reported

  9. Added to Calendar

  10. Conf Report Adopted

  11. Ordered Enrolled

  12. Conf Com Appointed

  13. Failed Concur In H Com Sub

  14. Conf Com Appointed

  15. Reptd Fav

  16. Cal Pursuant Rule 36(b)

  17. Added to Calendar

  18. Passed 2nd Reading

  19. Passed 3rd Reading

  20. Special Message Sent To Senate

  21. Special Message Received For Concurrence in H Com Sub

  22. Placed On Cal For 06/19/2025

  23. Reptd Fav Com Substitute

  24. Re-ref Com On Rules, Calendar, and Operations of the House

  25. Withdrawn From Com

  26. Re-ref to the Com on Health, if favorable, Rules, Calendar, and Operations of the House

  27. Special Message Sent To House

  28. Special Message Received From Senate

  29. Passed 1st Reading

  30. Ref To Com On Rules, Calendar, and Operations of the House

  31. Amend Adopted A1

  32. Passed 2nd Reading

  33. Passed 3rd Reading

  34. Engrossed

  35. Reptd Fav

  36. Reptd Fav Com Substitute

  37. Com Substitute Adopted

  38. Re-ref Com On Rules and Operations of the Senate

  39. Reptd Fav Com Substitute

  40. Com Substitute Adopted

  41. Re-ref Com On Finance

  42. Reptd Fav Com Substitute

  43. Com Substitute Adopted

  44. Re-ref Com On Commerce and Insurance

  45. Passed 1st Reading

  46. Ref To Com On Rules and Operations of the Senate

  47. Withdrawn From Com

  48. Re-ref to Health Care. If fav, re-ref to Commerce and Insurance. If fav, re-ref to Finance. If fav, re-ref to Rules and Operations of the Senate

  49. Filed

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

2 sponsors · 24 co-sponsors · 153 not signed on · 1 voted No

Sponsors (2)

Co-sponsors (24)

Not signed on (153)

153 members have not signed on to this bill.

Show all 153 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

C RPT Adoption

Passed 106 Yea · 0 Nay · 14 Other
Party YeaNayPresentNot Voting
Democratic 42002
U 2000
Unaffiliated 5001
Republican 570011
Total 1060014
% of votes cast 88%0%0%12%
How each member voted (120)
Member Party Vote
CharlesSmith — Yea
vonHaefen — Yea
Campbell — Yea
Reeder — Yea
C. Smith — Not Voting
F. Jackson — Yea
Abe Jones Democratic Yea
Aisha O. Dew Democratic Yea
Allen Buansi Democratic Yea
Allison A. Dahle Democratic Yea
Amber M. Baker Democratic Not Voting
Amos L. Quick, III Democratic Yea
B. Ray Jeffers Democratic Yea
Becky Carney Democratic Yea
Beth Helfrich Democratic Yea
Brandon Lofton Democratic Yea
Brian Turner Democratic Yea
Bryan Cohn Democratic Yea
Carolyn G. Logan Democratic Yea
Cecil Brockman Democratic Yea
Cynthia Ball Democratic Yea
Dante Pittman Democratic Yea
Deb Butler Democratic Yea
Eric Ager Democratic Yea
Garland E. Pierce Democratic Yea
Gloristine Brown Democratic Yea
James Roberson Democratic Yea
Jordan Lopez Democratic Yea
Julia Greenfield Democratic Yea
Kanika Brown Democratic Yea
Laura Budd Democratic Yea
Lindsey Prather Democratic Yea
Marcia Morey Democratic Yea
Maria Cervania Democratic Yea
Mary Belk Democratic Yea
Mike Colvin Democratic Yea
Monika Johnson-Hostler Democratic Not Voting
Phil Rubin Democratic Yea
Pricey Harrison Democratic Yea
Renée A. Price Democratic Yea
Robert T. Reives, II Democratic Yea
Rodney D. Pierce Democratic Yea
Sarah Crawford Democratic Yea
Shelly Willingham Democratic Yea
Terry M. Brown Jr. Democratic Yea
Tim Longest Democratic Yea
Tracy Clark Democratic Yea
Vernetta Alston Democratic Yea
Ya Liu Democratic Yea
Zack Hawkins Democratic Yea
A. Reece Pyrtle, Jr. Republican Yea
Allen Chesser Republican Yea
Ben T. Moss, Jr. Republican Yea
Bill Ward Republican Yea
Blair Eddins Republican Yea
Brenden H. Jones Republican Not Voting
Brian Biggs Republican Yea
Brian Echevarria Republican Yea
Celeste C. Cairns Republican Yea
Charles W. Miller Republican Yea
Chris Humphrey Republican Yea
Cody Huneycutt Republican Yea
David Willis Republican Yea
Dean Arp Republican Yea
Dennis Riddell Republican Yea
Destin Hall Republican Yea
Diane Wheatley Republican Yea
Donna McDowell White Republican Yea
Donnie Loftis Republican Not Voting
Donny Lambeth Republican Yea
Dudley Greene Republican Yea
Edward C. Goodwin Republican Yea
Erin Paré Republican Yea
Frank Iler Republican Yea
Harry Warren Republican Yea
Heather H. Rhyne Republican Yea
Howard Penny, Jr. Republican Not Voting
Hugh Blackwell Republican Yea
Jarrod Lowery Republican Yea
Jay Adams Republican Yea
Jeff Zenger Republican Yea
Jeffrey C. McNeely Republican Yea
Jennifer Balkcom Republican Yea
Jerry "Alan" Branson Republican Yea
Jimmy Dixon Republican Yea
John A. Torbett Republican Yea
John M. Blust Republican Not Voting
John R. Bell, IV Republican Yea
John Sauls Republican Not Voting
Jonathan L. Almond Republican Yea
Joseph Pike Republican Yea
Julia C. Howard Republican Yea
Karl E. Gillespie Republican Yea
Keith Kidwell Republican Yea
Kelly E. Hastings Republican Yea
Kyle Hall Republican Yea
Larry C. Strickland Republican Yea
Larry W. Potts Republican Yea
Mark Brody Republican Yea
Mark Pless Republican Not Voting
Matthew Winslow Republican Yea
Mike Clampitt Republican Not Voting
Mike Schietzelt Republican Yea
Mitchell S. Setzer Republican Yea
Neal Jackson Republican Not Voting
Paul Scott Republican Yea
Phil Shepard Republican Yea
Ray Pickett Republican Yea
Sam Watford Republican Not Voting
Sarah Stevens Republican Yea
Stephen M. Ross Republican Yea
Steve Tyson Republican Not Voting
Ted Davis, Jr. Republican Yea
Todd Carver Republican Yea
Todd Johnson Republican Yea
Tricia Ann Cotham Republican Not Voting
William D. Brisson Republican Yea
Wyatt Gable Republican Yea
Carla D. Cunningham U Yea
Nasif Majeed U Yea

Official roll call →

Second Reading

Passed 36 Yea · 2 Nay · 12 Other
Party YeaNayPresentNot Voting
Democratic 8007
Unaffiliated 7100
Republican 21104
Total 362011
% of votes cast 73%4%0%22%
How each member voted (49)
Member Party Vote
Bode — Yea
Hunt — Yea
Marcus — Yea
Woodard — Yea
Krawiec — Yea
Proctor — Yea
Perry — Nay
P. Newton — Yea
Dan Blue Democratic Yea
DeAndrea Salvador Democratic Yea
Gale Adcock Democratic Yea
Gladys A. Robinson Democratic Not Voting
Graig Meyer Democratic Yea
Jay J. Chaudhuri Democratic Not Voting
Joyce Waddell Democratic Yea
Julie Mayfield Democratic Yea
Kandie D. Smith Democratic Not Voting
Michael Garrett Democratic Yea
Mujtaba A. Mohammed Democratic Not Voting
Natalie S. Murdock Democratic Not Voting
Paul A. Lowe, Jr. Democratic Not Voting
Sydney Batch Democratic Yea
Val Applewhite Democratic Not Voting
Amy S. Galey Republican Yea
Benton G. Sawrey Republican Yea
Bill Rabon Republican Not Voting
Bobby Hanig Republican Yea
Brad Overcash Republican Yea
Brent Jackson Republican Not Voting
Carl Ford Republican Yea
Danny Earl Britt, Jr. Republican Not Voting
David W. Craven, Jr. Republican Yea
Eddie D. Settle Republican Yea
Jake Johnson Republican Nay
Jim Burgin Republican Yea
Kevin Corbin Republican Yea
Lisa S. Barnes Republican Yea
Michael A. Lazzara Republican Yea
Michael V. Lee Republican Yea
Norman W. Sanderson Republican Yea
Paul Newton Republican Not Voting
Phil Berger Republican Yea
Ralph Hise Republican Yea
Steve Jarvis Republican Yea
Timothy D. Moffitt Republican Yea
Tom McInnis Republican Yea
Vickie Sawyer Republican Yea
W. Ted Alexander Republican Yea
Warren Daniel Republican Yea

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 479?
SB 479 is sponsored by Eddie D. Settle (Republican), Vickie Sawyer (Republican), Norman W. Sanderson (Republican), Bill Rabon (Republican), Brad Overcash (Republican), Paul Newton (Republican), Timothy D. Moffitt (Republican), Tom McInnis (Republican), Michael A. Lazzara (Republican), Steve Jarvis (Republican), Mark Hollo (Republican), Ralph Hise (Republican), Bobby Hanig (Republican), Warren Daniel (Republican), David W. Craven, Jr. (Republican), Jay J. Chaudhuri (Democratic), Jim Burgin (Republican), Bob Brinson (Republican), Woodson Bradley (Democratic), Phil Berger (Republican), Lisa S. Barnes (Republican), Amy S. Galey (Republican), Danny Earl Britt, Jr. (Republican), Benton G. Sawrey (Republican), Todd Johnson (Republican), and Brent Jackson (Republican).
What is the current status of SB 479?
This bill has been enacted into law. Introduced March 25, 2025. Enacted.
Where can I track SB 479?
Track SB 479 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 479

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 479

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →